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Abstract
Despite considerable research efforts, little is yet known about key epidemiological parameters of H5N1 highly pathogenic
influenza viruses in their avian hosts. Here we show how these parameters can be estimated using a limited number of birds
in experimental transmission studies. Our quantitative estimates, based on Bayesian methods of inference, reveal that (i) the
period of latency of H5N1 influenza virus in unvaccinated chickens is short (mean: 0.24 days; 95% credible interval: 0.099–
0.48 days); (ii) the infectious period of H5N1 virus in unvaccinated chickens is approximately 2 days (mean: 2.1 days; 95%CI:
1.8–2.3 days); (iii) the reproduction number of H5N1 virus in unvaccinated chickens need not be high (mean: 1.6; 95%CI:
0.90–2.5), although the virus is expected to spread rapidly because it has a short generation interval in unvaccinated
chickens (mean: 1.3 days; 95%CI: 1.0–1.5 days); and (iv) vaccination with genetically and antigenically distant H5N2 vaccines
can effectively halt transmission. Simulations based on the estimated parameters indicate that herd immunity may be
obtained if at least 80% of chickens in a flock are vaccinated. We discuss the implications for the control of H5N1 avian
influenza virus in areas where it is endemic.
Citation: Bouma A, Claassen I, Natih K, Klinkenberg D, Donnelly CA, et al. (2009) Estimation of Transmission Parameters of H5N1 Avian Influenza Virus in
Chickens. PLoS Pathog 5(1): e1000281. doi:10.1371/journal.ppat.1000281
Editor: Ron A. M. Fouchier, Erasmus Medical Center, The Netherlands
Received September 18, 2008; Accepted December 26, 2008; Published January 30, 2009
Copyright:  2009 Bouma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The research in this manuscript was funded by the Dutch Ministry of Agriculture, Nature and Food Safety, and was carried out within the framework of
the Indonesian-Dutch partnership for the control of avian influenza in Indonesia. CAD acknowledges the MRC for Centre funding support. The funding body
played no role in the design, conduct, and analysis of the study, nor did it play a role in the writing of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: michiel.van.boven@rivm.nl
Introduction
Highly pathogenic avian influenza virus strains of the H5 or H7
subtypes are noted for being highly contagious among various bird
species and inducing high mortality rates in poultry. Although
outbreaks of highly pathogenic avian influenza have been reported
since the 1950s the current focus is on the H5N1 subtype. The first
outbreaks of H5N1 were reported in Hong Kong in 1997 [1–2].
Since then the virus has spread to South East Asia, Africa, and
Europe. The outbreaks in Europe were controlled by rapid
depopulation of infected premises, pre-emptive culling of neigh-
bouring farms, movement restrictions, and zoo-sanitary measures
[3–5]. In Asia, however, the disease has become endemic, and
control by means of culling in conjunction with movement
restrictions and zoo-sanitary measures is both infeasible socio-
economically and unlikely to result in elimination [6–10].
Therefore, vaccination is the most widely used containment
strategy. For instance, in Indonesia alone more than 400 million of
vaccine doses have been administered since 2004.
Despite the fact that aspects of H5N1 avian influenza biology
have been studied in detail, ranging from molecular studies of host
range factors, phylogenetic analyses aimed at unravelling the virus’
evolutionary pathways, surveillance of H5N1 in wild birds, studies
into the clinical course of H5N1 infections in humans, and vaccine
efficacy and safety studies, there is scant information of the basic
epidemiological characteristics of H5N1 viruses in their avian
hosts. Specifically, little is known about the infectious period of
H5N1 in various host species, the duration of the latent period,
and the transmissibility of the virus from bird to bird. For a proper
understanding of the transmission dynamics of the virus and to be
able to assess the potential impact of control measures such as
vaccination, however, this information is crucial. For instance, it is
well-known that both the invasion prospects of the virus as well as
the number of individuals ultimately infected are critically affected
by the (distribution of the) infectious period and transmission
parameter. The (distribution of the) period of latency is also of
importance since it is a key factor affecting the initial growth rate
and duration of an epidemic [11–13].
Here we present and analyze experimental transmission studies
with highly pathogenic H5N1 avian influenza virus (A/Chicken/
Legok/2003) in chickens to obtain quantitative estimates of key
epidemiological parameters. Specifically, we performed experi-
ments in which an artificially infected chicken was placed in a cage
with a susceptible contact bird, and in which the transmission
chain was monitored by taking daily samples from the trachea and
cloaca [14–16]. The samples were subsequently tested for the
presence of virus by egg-culture. In addition, blood samples were
taken weekly to determine the antibody response to infection. In
all, two experiments, each containing 11 trials, were carried out
with unvaccinated chickens, two experiments of 11 trials were
performed using an H5N1 inactivated oil emulsion vaccine which
contains a strain that is identical to the challenge virus (A/
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carried out with two heterologous H5N2 inactivated oil emulsion
vaccines (A/Turkey/England/N28/73 and A/Chicken/Mexico/
232/94/CPA) that are both genetically and antigenically distant
from the challenge virus.
The experiments are analyzed by tailored statistical methods
based on a SEIR (susceptible-exposed-infectious-removed) epide-
miological model. In this way all estimated parameters have a
clear-cut biological interpretation (mean and variance of the latent
and infectious period, transmission rate, reproduction number).
Here we use two different methods of analysis. The first uses final
size data i.e. the number of birds that are ultimately infected, and
is aimed at estimation of the reproduction number [17]. The
second approach uses all available information and is based on
Bayesian inference that relies on Markov Chain Monte Carlo
(MCMC) techniques [18–21]. This allows one to estimate not only
the reproduction number, but also other epidemiological param-
eters of interest. The main advantage of our controlled
experimental setup over field studies [6,7,22] is that the
parameters of interest can be estimated with high precision using
a limited number of birds. In addition, our controlled experimen-
tal setup makes it possible to ascribe differences between control
and treatment groups directly to the treatment without having to
take into account the potential effect of confounding variables
(e.g., age and size of the birds, stocking density, feeding status).
Results
Infection and disease
All inoculated unvaccinated birds (Tables 1 and 2) showed signs of
infection (depression, labored breathing), shed virus from both the
trachea and cloaca (apart from a single bird in Table 2), and died
within a few days after infection (range: day 2–day 3). Furthermore,
all contact birds died on day 4 or on day 5 after infection of the
inoculated bird, indicating rapid infection as well as rapid progression
of the disease towards death. In the experiments with unvaccinated
birds 8 out of 22 birds escaped infection. These birds did not show
signs of disease, did not shed detectable virus, and remained
serologically negative when tested in the HI assay at days 7 and 14.
In the experiments with vaccinated birds no contact birds were
infected and only a few of the inoculated birds shed virus on just a
few days. In fact, only 7 out of 66 inoculated birds shed virus for a
total of 12 days. Of these, virus was isolated from the trachea only
on 11 days and from the trachea and cloaca on a single day. None
of the vaccinated birds died in the course of the experiments, and
no signs of disease were observed in any of the vaccinated birds.
Details of the vaccination experiments are given in Tables S2, S3,
S4, S5, S6, and S7.
Transmission in unvaccinated versus vaccinated birds
With regard to transmission, the final size analyses indicate that
there are significant differences between the experiments with
unvaccinated and vaccinated birds. Table 3 summarizes the
results. For the low-dose experiment with unvaccinated birds
estimates of the reproduction number are 9.0 (95% confidence
interval (CI): 1.9–86) in case of an exponentially distributed
infectious period and 3.4 (95%CI: 1.3–7.6) in case of a fixed
infectious period. For the high-dose experiment the estimates of
the reproduction number are 1.7 (95%CI: 0.40–6.6) in case of an
exponentially distributed infectious period and 1.2 (95%CI: 0.37–
2.9) in case of a fixed infectious period. Although the difference
Table 1. Overview of the transmission experiment with
unvaccinated birds (low infection dose)*.
bird type days post challenge
01234567
i 2/2 +/++ /+ {
c 2/22 /22 /2 +/+ {
i 2/2 +/++ /+ {
c 2/22 /2 +/2 +/+ {
i 2/2 +/++ /+ {
c 2/2 +/+ 2/2 +/+ 2/+ {
i 2/2 +/++ /+ {
c 2/22 /22 /22 /22 /22 /22 /22 /2
#
i 2/2 +/++ /+ {
c 2/22 /2 +/2 +/++ /+ {
i 2/2 +/2 +/+ {
c 2/22 /22 /22 /22 /22 /22 /22 /2
#
i 2/2 +/++ /+ {
c 2/22 /2 +/2 +/++ /+ {
i 2/2 +/++ /+ {
c 2/22 /22 /2 +/++ /+ {
i 2/2 +/++ /+ {
c 2/22 /2 +/2 +/++ /+ {
i 2/2 +/++ /+ {
c 2/22 /2 +/2 +/+ {
i 2/2 +/++ /+ {
c 2/22 /22 /2 +/+ {
*the infection dose is 0.2 ml of 10
5 EID50 intranasally (0.1 ml) and intraocularly
(0.1 ml).
i: inoculated bird; c: contact bird; x/y: test result for virus isolation in the
trachea/cloaca.
{bird died.
#the bird was alive at the end of the experiment and tested negative in the
serological test.
doi:10.1371/journal.ppat.1000281.t001
Author Summary
Outbreaks of highly pathogenic H5N1 avian influenza in
poultry first occurred in China in 1996. Since that time, the
virus has become endemic in Asia, and has been the cause
of outbreaks in Africa and Europe. Although many aspects
of H5N1 virus biology have been studied in detail,
surprisingly little is known about the key epidemiological
parameters of the virus in its avian hosts (the length of
time from infection until a bird becomes infectious, the
duration of infectiousness, how many birds each infectious
bird will infect). In this paper we show, using experimental
transmission studies with unvaccinated and vaccinated
chickens, that H5N1 avian influenza induces a short
duration of infectiousness (,2 days) and a very short
period of time from infection until infectiousness (,0.25
day) in unvaccinated chickens. Furthermore, while trans-
mission was efficient among unvaccinated birds, no bird-
to-bird transmission was observed in vaccinated chickens.
Our results indicate that it may be difficult to curb
outbreaks by vaccination after an introduction in a flock
has been detected. On the other hand, preventive
vaccination could be effective in preventing virus intro-
ductions and limiting the size of outbreaks.
Transmission of H5N1 Influenza in Chickens
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(p=0.23) [23], it does hint at the possibility of a role of the
inoculation dose in impacting on the transmission dynamics. If all
experiments with unvaccinated birds are combined the outcome is
that 14 out of 22 initially susceptible contact birds are infected. In
this case the estimates of the reproduction number are 3.5
(95%CI: 1.4–9.6) and 2.0 (95%CI: 1.0–3.5), assuming exponen-
tially distributed and fixed infectious periods respectively,
indicating that the virus is able to spread epidemically in
unvaccinated populations.
No transmission was observed in all six experiments with
vaccinated birds, resulting in a maximum likelihood estimate of
the reproduction number of 0. The (two-sided) 95% confidence
interval ranges from 0–0.80 or 0–0.67, depending on the
assumptions regarding the distribution of the infectious period.
Furthermore, the null-hypothesis that the reproduction number is
larger than the threshold value 1 can safely be rejected (p=0.011
in case of an exponentially distributed infectious period, and
p=0.0041 in case of a fixed infectious period). Hence, it is unlikely
that an epidemic can occur in vaccinated populations.
Transmission dynamics in unvaccinated birds
The experiments with unvaccinated birds are analyzed using
Bayesian methods to obtain estimates of the transmissibility of the
virus and the distributions of the latent and infectious periods.
Table 4 and Figures 1–3, S1, S2, S3, S4, and S5 summarize the
main findings. In the low-dose experiment (Table 1) as well as the
high-dose experiment (Table 2) the estimated mean of the latent
period (or, more precisely, the median of the marginal posterior
distribution of the parameter determining the mean) is small (0.20
(day) or 0.44 (day)), as is the variance of the latent period (0.044 or
0.078) (Figures S1 and S2). The estimated means of the
transmission parameter are also comparable in the two experi-
ments, ranging from 0.74 (day
21) in the high-dose experiment to
0.80 (day
21) in the low-dose experiment. With regard to the
infectious period, however, there appear to be differences between
the low- and high-dose experiments, with the birds in the low-dose
experiment having a substantially longer infectious period. In fact,
the estimated mean of the infectious period is 2.5 (day) (95%CI:
2.2–2.8 (day)) for the low-dose experiment, and 1.3 (day) (95%CI:
0.92–1.8 (day)) for the high-dose experiment. In both experiments
the estimated variance of the infectious period is small (0.16 or
0.13), indicating that the infectious period distribution is narrowly
centered around the mean.
We then analyzed the data of the low- and high-dose
experiments simultaneously to obtain more precise estimates of
the parameters of interest. We considered three scenarios (labeled
by B, C, and D) that differ with regard to assumptions on the latent
and infectious periods (see Methods). Analysis of the pooled data
(scenario B) verifies the earlier indications (scenarios A1–A2) that
both the estimated mean and variance of the latent period are
small, while the estimated mean of the infectious period (2.1 (day))
lies between the estimated means of the infectious period in the
analyses of the low- and high-dose experiments (Figure 1). In
comparison with the separate analyses of the low- and high-dose
experiments the estimated variance of the infectious period
increases (0.16 and 0.13 in the low- and high-dose experiments
Table 2. Overview of the transmission experiment with
unvaccinated birds (high infection dose)*.
bird type days post challenge
012345 6 7
I 2/2 +/+ {
C 2/22 /22 /22 /2 {
i 2/22 /+ {
c 2/22 /22 /2
#
i 2/2 +/+ {
c 2/22 /22 /2
#
i 2/22 /+ {
c 2/22 /22 /2
#
i 2/2 +/+ {
c 2/22 /22 /2
#
i 2/2 +/+ {
c 2/22 /22 /2
#
i 2/2 +/+ {
c 2/22 /22 /2
#
i 2/2 +/+ {
c 2/22 /22 /2 +/+ {
i 2/2 +/++ /2 {
c 2/22 /22 /22 /22 /+ {
i 2/2 +/+ {
c 2/22 /22 /2 +/+ {
i 2/2 +/+ 2/2 {
c 2/22 /2 +/2 +/+ {
*the infection dose is 0.2 ml of 10
6 EID50 intranasally (0.1 ml) and intraocularly
(0.1 ml).
i: inoculated bird; c: contact bird; x/y: test result for virus isolation in the
trachea/cloaca.
{the bird died.
#the bird was alive at the end of the experiment and tested negative in the
serological test.
doi:10.1371/journal.ppat.1000281.t002
Table 3. Overview of the final size analyses.
experiment final size ^ Rexp
* ^ Rfix
* H0 :R §1
#
low dose (N=11) 9 9 (1.9–86) 3.4 (1.3–7.6) 1.0/1.0
high dose (N=11) 5 1.7 (0.40–6.6) 1.2 (0.37–2.9) 0.88/0.77
vaccination
x (N=11) 0 0 (0–0.80) 0 (0–0.67) 0.011/0.0041
*maximum likelihood estimates of the reproduction number with 95% confidence intervals (between brackets) if the infectious period is exponentially distributed (Rexp)
or of fixed duration (Rfix).
#p-values of the null hypothesis under the assumption of an exponentially distributed and fixed infectious period.
xall experiments with vaccinated birds (Table S1) yielded a final size of 0. Shown are the results for a single vaccination experiment.
doi:10.1371/journal.ppat.1000281.t003
Transmission of H5N1 Influenza in Chickens
PLoS Pathogens | www.plospathogens.org 3 January 2009 | Volume 5 | Issue 1 | e1000281versus 0.33 in scenario B), probably because of the need to
accommodate both short (,1.5 (day)) and long (,2.5 (day))
infectious periods. Alternatively, if the infectious period distribu-
tions are allowed to differ between the low- and high-dose
experiments (scenario C), then the estimated mean infectious
periods as well as the corresponding variance estimates revert to
values close to those in the separate analyses of the low- and high-
dose experiments (Figure 2). Based on Bayes factor (see Methods)
the model that allowed for differences in the infectious periods has
substantially higher support (BF=21 for the pair of simulations of
competing models with the smallest difference in marginal
likelihoods) than the model in which the infectious period
distributions in the low- and high-dose experiments are assumed
to be equal. Finally, if the latent and infectious period distributions
are allowed to differ between inoculated and contact birds
(scenario D; Figure 3) there is some evidence that, overall, the
infectious period of the contact infected birds was somewhat
longer than that of the artificially infected birds (mean 2.5
(day)(95%CI: 1.9–3.3) versus mean 1.7 (day)(95%CI: 1.4–2.1)).
Figure 3 furthermore shows that the variances of the latent and
infectious period distributions of the contact infected birds could
not be estimated with precision. An extended analysis including
alternative informative prior distributions and an artificially
extended dataset indicate that this is indeed the case, and that
the experiments of Table 1 and 2 do not contain sufficient
information to estimate the variance of the latent and infectious
periods of the contact infected birds (unless substantial prior
information is added)(results not shown).
Two derived epidemiological measures of interest are the
reproduction number R and the generation interval Tg [11–13]. In
our setting the reproduction number is given by the product of the
infectious period and the transmission rate, while the generation
interval is defined as the moment of infection of the contact bird,
relative to the time at which the inoculated bird was returned to
the cage following inoculation. Overall, the generation interval
ranges from an estimated mean of 1.2 (day) in scenario A1 and
scenario D to 1.8 (day) in scenario A2, with limited variation
around these estimates. This indicates that the generation interval
is short, and lies in the range of 1–2 days. With regard to the
reproduction number, we find substantial differences in the
reproduction number between the low- and high-dose experi-
ments. In fact, the estimated reproduction number is 2.0 (95%CI:
0.96–3.6) in the low-dose experiment, and 0.99 (95%CI: 0.38–2.1)
in the high-dose experiment. This difference can be ascribed to
differences in the mean infectious period in the low- versus high-
dose experiments (Table 4). If the data of the low- and high-dose
experiments are pooled and assumed to have the same infectious
period distribution (scenario B), the estimated reproduction
number lies between the above extremes (1.6; 95%CI: 0.90–2.5).
Alternatively, if the data are pooled but the infectious period
distributions are allowed to vary between the low- and high-dose
experiments, the (infection-type specific) estimated reproduction
numbers are 1.8 (95%CI: 1.1–3.0) and 1.2 (95%CI: 0.71–2.0) in
the low- and high-dose experiments, respectively.
Simulated epidemics
To explore the implications of the parameter estimates for the
dynamics of H5N1 avian influenza in large populations of poultry
we have performed stochastic simulations of an SEIR model using
the parameter estimates presented in Table 4. The parameters
determining the latent and infectious periods can directly be
plugged into the model, but some care should be taken with the
transmission parameter as it is not obvious how the parameter
determining transmission between two individuals should be
extrapolated to larger populations. The two common assumptions
are that each individual makes a fixed number of contacts per unit
of time regardless of population size (the frequency dependent
transmission assumption), or that each individual makes a fixed
number of contacts with each of the other individuals in the population
per unit of time (the density dependent transmission assumption)
Table 4. Overview of the Bayesian analyses.
scenario description b (day
21)
* ªE (day)
* dE
* ªI (day)
* dI
* R
* Tg (day)
*
A1 low-dose experiment 0.80 0.20 0.044 2.5 0.16 2.0 1.2
(0.38–1.5) (0.049–0.43) (0.0020–0.45) (2.2–2.8) (0.045–0.48) (0.96–3.6) (0.94–1.5)
A2 high-dose experiment 0.74 0.44 0.078 1.3 0.13 0.99 1.8
(0.27–1.6) (0.14–0.87) (0.0026–1.1) (0.92–1.8) (0.0097–0.66) (0.38–2.1) (1.3–2.3)
B combined analysis 0.76 0.24 0.043 2.1 0.33 1.6 1.3
(0.42–1.2) (0.099–0.48) (0.0039–0.36) (1.8–2.3) (0.15–0.77) (0.90–2.5) (1.0–1.5)
C differences in the mean
infectious period
0.73 0.20 0.035 2.5
# (2.2–2.8) 0.15 1.8
# (1.1–3.0) 1.3
(0.43–1.2) (0.094–0.45) (0.0030–0.54) 1.7
# (1.4–2.0) (0.049–0.58) 1.2
# (0.71–2.0) (1.1–1.5)
D differences between
inoculated/contact birds
x
0.44 0.038 1.7 0.19
0.81 (0.18–0.70) (0.0011–0.53) (1.4–2.1) (0.025–0.58) 2.0 1.2
(0.44–1.3) 0.62 2.4 2.5 0.96 (1.0–3.5) (1.2–1.3)
(0.21–1.0) (0.26–4.9) (1.9–3.3) (0.31–3.7)
Cells show the median of the marginal posterior distributions with 95% credible intervals (between brackets).
*b: transmission rate parameter; cE: mean of the latent period; dE: variance of the latent period; cI: mean of the infectious period; dI: variance of the infectious period; R:
reproduction number; Tg: generation interval.
#the upper and lower rows give the parameter estimates for the low and high dose experiments, respectively.
xthe upper and lower rows give the parameter estimates for the inoculated and contact birds, respectively. The estimate of the reproduction number is based on the
infectious period of the contact infected birds.
doi:10.1371/journal.ppat.1000281.t004
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the total number of contacts that an individual makes per unit of
time does not depend on total population size, while under the
density dependent transmission assumption the number of
contacts that an individual makes per unit of time increases
linearly with total population size [24]. It is plausible that for small
to moderately sized populations the transmission rate increases
monotonically with increasing population size and that this
increase flattens off as population size becomes large (birds cannot
increase their activity levels indefinitely). Here we perform
simulations of populations of 10,000 birds. In the simulations we
first use the transmissibility estimates presented in Table 4, which
we subsequently multiply by a factor 2. This implies that in our
simulations birds in a population of 10,000 are either as active as
birds that are kept in pairs, or twice as active as birds in pairs.
Figure 4 shows two representative simulations of an epidemic in
a population of 10,000 individuals using the parameter estimates
of the low-dose experiment (Table 4). The top panel shows the
time course of the epidemic in case of low transmissibility (leading
to a reproduction number of R=2.0), while the bottom panel
shows the dynamics if the transmission rate parameter is increased
twofold (implying a reproduction number of R=4.0). The figure
shows that the epidemic unfolds in about a month (top panel) to
approximately two weeks (bottom panel), depending on whether
the transmission parameter is small or large. Furthermore, the
figure shows that the peak prevalence is about 25% of total
population size if transmissibility is low, and approaches 65% if
transmissibility is high. Increasing the virus’ transmissibility from
twofold to, say, tenfold leads to minor changes in the infection
dynamics as every susceptible individual is already very quickly
(within a time span of a week) infected in the high transmissibility
scenario (results not shown). It is of note that in comparison with
standard stochastic models that assume exponentially distributed
latent and infectious periods the epidemics in Figure 4 are
considerably more peaked, while their durations are substantially
shorter (results not shown) [12].
Rapid detection of outbreaks of H5N1 highly pathogenic avian
influenza virus in poultry is of paramount importance for efficient
control within poultry flocks and to be able to minimize the
opportunities of virus transmission between flocks [26–28]. If we
assume that avian influenza can be detected with high specificity if
mortality is at least 0.5% on two consecutive days [26,29], then an
outbreak will be detected in our simulations between days 11 and
12 after introduction if transmissibility is low, and between days 7
and 8 if transmissibility is high (see the blue arrows in Figure 4). In
case of low transmissibility, this gives a window of opportunity of at
most ten days to reduce the infectious output of the flock
(Figure 4A). If, however, transmissibility is high, circulation of the
virus will only be detected near the moment of peak infectivity,
and there is a window of opportunity of at most five days for
control measures to be effective in reducing the infectious output
of infected flocks once they are detected (Figure 4B). Overall, our
simulations indicate that control of H5N1 avian influenza in
poultry flocks once an outbreak has been detected may be more
difficult than hitherto thought [22,26–27].
Figure 1. Bayesian analysis of the experiments with unvacci-
nated birds (scenario B). Shown are samples from the marginal
posterior density of the mean versus variance of the latent period (A),
the mean versus variance of the infectious period (B), and the mean
infectious period versus transmission rate parameter (C). The contours
in (C) correspond to specific values of the reproduction number. See
Figures S1, S2, and S3 for additional results.
doi:10.1371/journal.ppat.1000281.g001
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To further investigate the potential for control by vaccination
we have carried out simulations using estimates of the epidemi-
ological parameters (Table 4) and efficacy of vaccination (Table
S1). Because of the reasons discussed above, it is highly unlikely
that an outbreak can be controlled by vaccination once it has been
detected. Adding to this is the fact that it may take 7–10 days for
vaccination to become effective in interfering with transmission
[14–16]. However, it may still be possible to prevent or curb
outbreaks by preventive vaccination.
Figure 5 gives an overview of the fraction of outbreaks that yield
a major outbreak (numbers near circles), the size of the major
outbreaks (circles), and the duration of the epidemics (squares) as a
function of the fraction of birds that is vaccinated prior to
introduction of the virus. If transmissibility is low (cf.
Figure 4A)(blue lines), the probability of a major outbreak as well
as the size of the major outbreaks decrease with increasing
vaccination coverage. The duration of major outbreaks, however,
increases with increasing vaccination coverage [11–12]. Major
outbreaks cannot occur for the parameters presented in Table 4 if
coverage is at least 60%. If, on the other hand, pathogen
transmissibility is high (cf. Figure 4B)(red lines), then the
probability of a major epidemic and final size of the epidemics
increase in comparison with the low-transmissibility scenario,
while the duration of the epidemics decreases [11]. Still, both the
probability of a major outbreak as well as the size of the outbreak
decrease with increasing vaccination coverage, and major
outbreak cannot occur if vaccination coverage is at least 80%.
Summarizing, our simulations indicate that it is possible to attain a
state of herd immunity by incompletely vaccinating flocks of
chickens even if birds are assumed to make twice as many contacts
per unit of time as estimated in our transmission experiments.
Discussion
In this study we have attempted to fill the remarkable void of
quantitative information on key epidemiological parameters of
H5N1 highly pathogenic avian influenza in chickens. Our results
indicate that H5N1 virus induces a short period of latency and a
short infectious period. In fact, our estimate of the mean of the
latent period varies from 0.20 days (95%CI: 0.049–0.43 days) in
scenario A1 to 0.44 days (95%CI: 0.14–0.87 days) in scenario A2
(Table 4). Likewise, the mean infectious period varies from 1.3
days (95%CI: 0.92–1.8 days) in scenario A2 to 2.5 days (95%CI:
2.2–2.8 days) in scenario A1. Estimates of the variance of the
infectious period are generally low, much lower than the
corresponding means (Table 4). This implies that the distributions
of the infectious periods are fairly narrow. Similar results were
reported by Carrat and colleagues [30] who found that shedding
of human influenza viruses increased sharply 0.5–1 day after
infection, while the infectious period was centered narrowly
around five days.
Our estimates of the transmission parameter are remarkably
similar across the different datasets and model scenarios. The
estimate of the transmission parameter is lowest if the data of all
Figure 2. Bayesian analysis of the experiments with unvacci-
nated birds (scenario C). Shown are samples from the marginal
posterior density of the mean versus variance of the latent period (A),
the mean versus variance of the infectious period (B), and the mean
infectious period versus transmission rate parameter (C). Blue and red
dots refer to parameters characterizing the low- and high-dose
experiments, respectively. The contours in (C) correspond to specific
values of the reproduction number. See Figure S4 for additional results.
doi:10.1371/journal.ppat.1000281.g002
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1.2 per day) and highest if the analysis allows for differences
between inoculated and contact birds (median: 0.81 per day;
95%CI: 0.44–1.3 per day). In combination with the estimates of
the mean infectious period these estimates yield estimates of the
reproduction number varying from 0.99 (95%CI: 0.38–2.1) in the
high-dose experiment (scenario A2) to 2.0 (95%CI: 0.96–3.6) in
the low-dose experiment (scenario A1).
In view of the generally held belief that highly pathogenic avian
influenza viruses spread easily and rapidly among chickens [14–
16,22,26–27] our estimates of the reproduction number may seem
low. In this respect a number of points are worth of discussion.
First, we have assumed frequency dependent transmission, which
assumes that each bird makes a fixed number of contacts per unit
of time, regardless of the size of the population [24]. This is
convenient since it allows one to directly extrapolate from small to
large populations. The reason is that under this assumption the
reproduction number does not depend on total population size.
There is, moreover, evidence that a frequency dependent
transmission model provides a better description of the pathogen
dynamics than a density dependent model in farm animals that are
generally held at a constant stocking density [31]. Still, some
uncertainty remains as to how our estimates of the transmission
parameter and infectious period should be combined into an
estimate of the reproduction number. To address this potential
problem we have in our simulations included a high transmissi-
bility scenario (Figures 4 and 5) that in essence assumes that birds
in large populations are twice as active as birds in our transmission
experiments with pairs of birds.
Second, it is not straightforward to extrapolate our results that
were obtained in an experimental setting to the situation in the
field. This is especially so for estimates of the transmission
parameter, which are the result not only of an autonomous process
of viral replication and interaction of the pathogen with the
immune system within a single host, but also of an interaction
between different individuals. Ambient temperature, stocking
density, feeding status of the birds, etcetera could all impact on
this interaction and critically affect estimates of the transmission
parameter. To counter this we have tried to match the conditions
in our experiments to those in commercial laying chicken farms.
Reassuringly, a recent analysis of transmission of H5N1 in the field
[7] also indicates that the reproduction number of H5N1 virus
among chickens is fairly low, ranging from 2.0 to 3.5. This suggests
that our estimates of the reproduction number obtained using
pairs of birds are low but not unreasonable.
A third point that deserves attention is the fact that housing
systems of layer flocks vary from floor systems in which birds can
mingle freely to caged systems in which no direct contact between
(groups of) birds is possible. In principle, our study is aimed at
quantifying transmission in a situation where there is direct contact
between birds, corresponding to a floor system. However, the lone
study that focused on within-flock transmission (mostly backyard
flocks) did not find differences between different housing systems,
suggesting that if there are differences in the transmission
dynamics they cannot be large [7]. Nevertheless, more information
Figure 3. Bayesian analysis of the experiments with unvacci-
nated birds (scenario D). Shown are samples from the marginal
posterior density of the mean versus variance of the latent period (A),
the mean versus variance of the infectious period (B), and the mean
infectious period versus transmission rate parameter (C). Dots refer to
parameters characterizing the contact infections. The contours in (C)
correspond to specific values of the reproduction number. See Figure
S5 for additional results.
doi:10.1371/journal.ppat.1000281.g003
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PLoS Pathogens | www.plospathogens.org 7 January 2009 | Volume 5 | Issue 1 | e1000281Figure 4. Simulations of an epidemic in a population of 50,000 birds. Parameters values are based on the estimates of Table 4 (scenario A1).
A dot is plotted for the population state after each tenth event. (A) transmission parameter as in Table 4 (0.8 (day
21)) and (B) transmission parameter
increased twofold (1.6 (day
21)).
doi:10.1371/journal.ppat.1000281.g004
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help bridging the gap between findings obtained in experimental
studies and the situation in the field.
While it is not straightforward to extrapolate from our
experimental setting to the field situation, experimental transmis-
sion studies also have distinct advantages over field studies. In
particular, while field studies often suffer from various sources of
bias and confounding, this is not the case in an experimental
setting. This allows one to directly ascribe differences between
control and treatment groups directly to the treatment (e.g.,
vaccination) since all other animal and environmental conditions
are held constant. Moreover, an experiment has the added
advantage over a field study that far fewer birds are needed and
that the birds can be sampled more often and efficiently than in a
field study. This has allowed us to obtain precise estimates of the
key epidemiological parameters of H5N1 highly pathogenic avian
influenza in unvaccinated chickens using no more than 50 birds.
Our results show remarkable differences between experiments
in which the inoculated bird received a low infection dose (0.2*10
5
EID50) and experiments in which the inoculated bird received a
high dose (0.2*10
6 EID50). Specifically, while 9 out of 11 birds
were infected in case of a low infection dose (Table 1), only 5 out of
11 were infected in case of a high infection dose (Table 2). This is
an interesting and counterintuitive result, which is likely to result
from the fact that the infectious period in the experiments in which
the inoculated bird received a high inoculation dose is significantly
smaller than in the experiments in which the inoculation dose was
low or in which the infectious period of the naturally infected birds
was estimated separately (low dose: mean 2.5 days (95%CI: 2.2–
2.8); high dose: mean 1.3 days (95%CI: 0.92–1.8); contact birds
only: mean 2.5 days (95%CI: 1.9–3.3)). Earlier experimental
transmission studies with H7N7 highly pathogenic avian influenza
virus (A/Chicken/Netherlands/621557/03) in a variety of birds
and H5N1 highly pathogenic avian influenza virus (A/Chicken/
China/1204/04, also designated A/Chicken/GxLA/1204/04) in
ducks used an infection dose of 0.2*10
6 EID50 since this yielded
comparable infections in inoculated and naturally infected animals
[14–16]. The finding that the infection dose is of importance in
determining the duration of infection is of both theoretical and
practical relevance as it suggests that the infection pressure in the
population may not only determine the incidence of infection but
also the course of infection. If it is typical that a low infection dose
is associated with a long infectious period while a high infection
dose generally leads to infections that are of short duration, then
this would necessitate a rethinking of the critical determinants of
H5N1 avian influenza transmission in populations of birds, and it
could potentially have profound implications for optimal control
and containment strategies.
To investigate the implications of our parameter estimates for
the dynamics of H5N1 avian influenza virus in large groups of
chickens we have carried out stochastic simulations. Since it is not
obvious how the transmission parameter as estimated between
pairs of chickens can be extrapolated to large populations, we
considered a low and high transmissibility scenario (Figure 4). The
simulations indicate that, even if we assume that the transmission
parameter is small, the epidemic usually unfolds in about a month,
and that once the epidemic has taken off it only takes about two
weeks to come to an end. If, as appears more likely, the
transmission rate is larger in large population than in populations
of two birds, then the epidemic takes off more quickly after a
primary introduction, and also comes to an end more quickly. For
control purposes this implies that it will be very difficult, if not
impossible, to effectively control an outbreak once it has been
detected. It may even prove difficult to reduce transmission
opportunities from an infected population (a farm, say) to
susceptible populations, as the number of dead birds may start
to rise just before peak infectivity (Figure 4). This suggests that
perhaps other indicators of infection, such as lethargy, reduced
feed or water intake should be added to the mortality indicator to
obtain a sensitive syndrome-reporting system [32].
Figure 5. The effect of preventive vaccination as a function of vaccination coverage. Circles refer to the final size of major outbreaks (error
bars: 62SD) and squares indicate the duration of major outbreaks (error bars: 62SD). Blue and red lines represent the low and high transmissibility
scenarios, respectively (cf. Figure 4). 100 simulations are performed for each parameter constellation. Numbers near the circles refer to the numbero f
simulations that yield a major outbreak. Major outbreaks are operationally defined as those outbreaks in which at least 50 birds are infected.
doi:10.1371/journal.ppat.1000281.g005
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chickens, no transmission was observed at all in the experiments
with inactivated oil emulsion vaccines (Tables S1, S2, S3, S4, S5,
S6, and S7). This was true not only for an H5N1 vaccine virus
which had 100% homology to the challenge virus, but also for
genetically distant heterologous viruses that contained inactivated
H5N2 viruses. These findings indicate that it is possible, at least in
principle, to reduce transmission by vaccination to the extent that
no epidemics can occur. This suggestion is corroborated by our
simulations which indicate that a vaccination coverage as low as
60%–80% may already be sufficient to obtain herd immunity
(Figure 5). Of course, it should be borne in mind that in our
experiments all birds received two vaccination doses, that the
timing of challenge (two weeks after the last vaccination bout) was
probably ideal, and that in the field there are various factors that
may interfere with vaccination (concurrent infections, immune
depression by various causes) [33]. Still, our results and those of
others [34–36] provide a proof-of-principle that herd immunity
can be obtained with currently available inactivated oil emulsion
vaccines. The finding that H5N1 avian influenza virus has a lower
transmissibility than hitherto believed [26] also implies that
outbreaks may be easier to prevent than previously thought, since
the reproduction number is already relatively close to the
threshold value of 1.
Methods
Birds and housing
All experiments were carried out in PT Medion laboratories in
Bandung, Indonesia, which have high containment facilities
(BSL3). In all experiments, specific pathogen-free (SPF) layer
chickens from the animal unit of Medion were used. The birds
were hatched and housed in one group until 4 weeks of age. At
that age, pairs of birds were housed in cages. Three rooms were
available to house the various vaccinated and unvaccinated pairs
of birds. Two rows with three levels of cages on top of each other
were available in each room. The rows with cages were separated
by a corridor of approximately 1 m width. The various rooms as
well as the rows with the cages had separate ventilation systems.
Each cage had a separate feeding and drinking system. The floor
and walls of each cage were covered with plastic to prevent spread
of manure or other materials between cages. When sampling the
birds, animal caretakers used a new pair of gloves for each cage.
Unvaccinated sentinel birds were placed at regular distances
between the cages used in the experiments to ensure that no
transmission had taken place between cages. All sentinels survived
and remained seronegative during the course of the experiments.
Virus, vaccines and inoculum
The challenge strain used in the experiments was A/Chicken/
Legok/2003 H5N1, a highly pathogenic H5N1 strain isolated in
Indonesia in 2003 which is genetically very close to strains that
circulate in Indonesia in 2008. The strain has been used in
experiments carried out at Medion and is able to induce infection,
typical signs of disease, and high mortality rates in chickens.
Inactivated oil emulsion vaccines were available from three
different manufactures: PT Medion (Bandung, Indonesia), PT
Vaksindo (Bogor, Indonesia) and Intervet (Mexico). The vaccines
contained either an H5N1 or H5N2 virus strain. The H5N1
vaccines contained A/Chicken/Legok/2003 H5N1, i.e. the vaccine
and challenge strains were identical. The H5N2 vaccines contained
either A/Turkey/England/N28/73 H5N2 or A/Chicken/Mex-
ico/232/94/CPA H5N2. The protein homologies of the antigenic
part of the hemagglutinin(HA1) of the challenge strainto the H5N2
A/Turkey/England/N28/73 and H5N2 A/Chicken/Mexico/
232/94/CPA vaccine strains are 92% and 86%, respectively.
All vaccines were re-vialed in coded bottles, and the identity of
the vaccines was not known to the staff involved in the experiment.
In this manner the experiments were double blinded.
Because the size of a natural infection dose is unknown the
inoculum consisted of diluted allantoic fluid containing either 10
5
EID50 per ml (low inoculation dose) or 10
6 EID50 per ml (high
inoculation dose). The birds were inoculated both intranasally
(0.1 ml) and intratracheally (0.1 ml). Virus titres were confirmed
before and after inoculation by titration on embryonated SPF eggs.
Experimental design
Each experiment consisted of a set of 11 trials. In each of the
trials an inoculated bird was placed in a cage with an uninfected
contact bird, and the transmission chain was monitored daily by
virus isolation performed on swabs taken from the trachea and
cloaca. In all, a total of eight experiments were carried out.
Unvaccinated birds were used in two experiments. In the first of
these the inoculated birds received a low infection dose, while in
the second the inoculated birds received a high infection dose. The
remaining six experiments with vaccinated birds differed with
respect to the vaccine used, the manufacturer, and the inoculation
dose. Tables 1 and 2 show the data of experiments with
unvaccinated birds, and Tables S1, S2, S3, S4, S5, S6, and S7
give an overview of the experiments with vaccinated birds.
At 4 weeks of age all birds of the vaccination experiments
received their first vaccination dose. A second vaccination was
carried out at 7 weeks of age. At 10 weeks of age (day 0) one bird
was chosen at random per cage, taken from the cage, and infected
intratracheally and intranasally. To avoid direct infection of the
contact bird by the inoculum the artificially infected birds were
placed back in their cages only after a delay of 8 hours.
Sampling and testing
Tracheal and cloacal swabs were taken daily for 10 days after
challenge from all birds. Swabs were incubated for 1 h in one ml
of PBS medium containing antibiotics. The medium was
subsequently stored at 270uC until testing. Three embryonated
SPF chicken eggs were injected with 0.2 ml of the swab medium
per egg. After culture for 4 days or when embryos died, the
allantoic fluid was harvested and a hemagglutination (HA) assay
was performed following standard procedures (www.oie.int). When
at least one of the eggs was positive in the hemagglutination assay
the swab was considered to be positive.
The serological status of the birds was determined just before
vaccination, at the start of the experiments just before inoculation
(day 0) and, for birds that survived, at the end of the experiments
(day 14). Serum blood samples were taken from all birds by
puncturing the wing vein. Blood samples were centrifuged and
serum was stored at 220uC until tested. The sera were tested in
the hemagglutination inhibition (HI) test according procedures
described in the Manual of Diagnostic Tests and Vaccines for
Terrestrial Animals of the OIE (www.oie.int) using 4 HA units
(HAU) of A/Chicken/Legok/03 H5N1 as antigen. Titres were
expressed as
2log of the serum dilution that caused complete
inhibition of agglutination, as specified by OIE guidelines.
Clinical signs of disease were recorded daily for a period of up to
10 days after challenge.
Statistical analysis
As a first step we estimated the reproduction number R by final
size methods [14–17]. Since each trial contains only one
inoculated bird and one susceptible contact bird, the likelihood
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L~Q
R
2
   N{n
1{Q
R
2
      n
: ð1Þ
In this equation N and n are the number of trials per experiment
and the number of infected contact birds, while Q x ½  represents the
Laplace transform of the infectious period probability distribution
when the mean infectious period is scaled to 1. Hence, Q x ½  ~ 1
1zx
in case of an exponentially distributed infectious period, and
Q x ½  ~exp {x ½  in case of a fixed infectious period. Table 3
provides estimates of the reproduction number with corresponding
95% confidence intervals, as well as p-values of the null-hypothesis
that the reproduction number is greater than or equal to the
threshold value of 1 [23].
In a second step, we estimated all parameters of interest by
Bayesian methods [18–21]. In the following we denote by b the
transmission rate parameter, by cE and dE the parameters
determining the latent period probability distribution, and by cI
and dI the parameters of the infectious period probability
distribution. We assume that the latent and infectious periods
are gamma distributed, and that ET E ½  ~cE and Var TE ½  ~dE,
and ET I ½  ~cI and Var TI ½  ~dI represent the means and
variances of these distributions. The corresponding probability
densities are denoted by fE x ðÞ and fI x ðÞ .
Further, ek, ik, and rk are N-dimensional vectors which contain
the time points of the SRE, ERI, and IRR transitions for
inoculated (k~1) and contact (k~2) birds in the N trials. Hence,
we have e1~ 0,...,0 ðÞ
T by definition, while all other transition
times are unknown. The unknown transitions are added in the
analyses by Bayesian imputation. We adopt the convention that e2j
denotes the exact time at which the contact bird in experiment j is
infected, that i1j denotes the exact time that the inoculated bird in
experiment j became infectious, etcetera.
With these notational conventions, the contribution of trial j to
the likelihood is given by
L j ðÞ ~
l
j ðÞe2j
  
S j ðÞe2j
  
fE i1j
  
fI r1j{i1j
  
fE i2j{e2j
  
fI r2j{i2j
  
if the contact bird was infected
S j ðÞr1j
  
fE i1j
  
fI r1j{i1j
  
if the contact bird was not infected:
8
> > > <
> > > :
ð2Þ
In the above equation l
j t ðÞ and S j ðÞt ðÞ denote the infection
hazard in trial j at time t and the probability that the contact bird
in trial j remains uninfected up to time t, respectively. If we let […]
denote the indicator function, the infection hazard is given by
l
j ðÞt ðÞ ~
b
2
max tadd,i1j
  
ƒtvr1j
  
, ð3Þ
where the parameter tadd represents the delay between the
moment of inoculation and the placing back of the inoculated
birds in their cages, and the function max tadd,i1j
  
marks the
beginning of the at-risk period for the contact bird. In all trials and
experiments, the delay is 8 hours, i.e. tadd~0:33 (day). The
probability that the contact bird in trial j remains uninfected up to
time t can be expressed in terms of the infection hazard as follows
S j ðÞt ðÞ ~e
{
Ð t
0
l j ðÞt’ ðÞ dt’
: ð4Þ
Using Equations (2)–(4) the likelihood function is given by the
product of the contributions of the individual trials:
L~ P
j[P
L j ðÞ , ð5Þ
where P represents the set of trials. Equations (2)–(5) form the basis
of the analyses in Figures 1, S1, S2, and S3.
The likelihood contribution in Equation (2) assumes that the
latent and infectious periods of inoculated and infectious birds are
identically distributed. To investigate the validity of these
assumptions we also considered a model which allows for
differences between the inoculated and contact birds. In this case,
the likelihood contribution becomes
L j ðÞ ~
l
j ðÞe2j
  
S j ðÞe2j
  
fE,1 i1j
  
fI,1 r1j{i1j
  
fE,2 i2j{e2j
  
fI,2 r2j{i2j
  
if the contact bird was infected
S j ðÞr1j
  
fE,1 i1j
  
fI,1 r1j{i1j
  
if the contact bird was not infected,
8
> > > > > <
> > > > > :
ð6Þ
where fE,k x ðÞ and fI,k x ðÞ are the probability density functions of
the latent and infectious periods of the inoculated birds (k~1) and
contact birds (k~2). The results of the analyses based on Equation
(6) are given in Figure 3 and Figure S5. In a similar manner, the
likelihood contribution in Equation (2) is adapted to allow for
differences in the infectious period in the low- versus high-dose
experiments. The results of these analyses are summarized in
Figure 2 and Figure S4.
Notice that, since the transmission rate in Equations (1), (2), and
(5) is divided by the total size of the population (i.e. 2), the above
model assumes frequency dependent transmission (as opposed to
density dependent transmission) [24]. For the present experimen-
tal setup with one inoculated bird and one contact bird, the value
of the transmission parameter of the density dependent model is
simply given by the transmission rate parameter of the frequency
dependent transmission model divided by 2 (the size of the
population). In case of a frequency dependent transmission model
the (basic) reproduction number is given by the product of the
transmission rate parameter and the mean infectious period:
R~bcI. In case of a density dependent transmission model the
reproduction number is a function of population size, and it is
given by RN ðÞ ~
b
2NcI, where b denotes the transmission
parameter of the frequency dependent model with two birds [25].
As in earlier papers [18–21] the epidemiological parameters of
interest (b, cE, dE, cI, and dI) were estimated by Bayesian methods
of inference using Markov Chain Monte Carlo. Throughout, all
prior distributions of the parameters were uniformly distributed on
the interval (0.001–5). As an alternative we also considered vague
gamma prior distributions, and obtained comparable results
(results not shown).
In our simulations the epidemiological parameters and
unobserved transitions were updated by a random-walk Metrop-
olis algorithm. We used Normal proposal distributions with the
current value as mean, and a standard deviation of 0.025, 0.05, or
0.1. The transmission parameters and unobserved transitions were
updated in blocks, in the order i1, r1, e2, i2, r2, and
b,cE,dE,cI,dI ðÞ
T. Notice that updating of the individual transition
vectors needs to take into account the infection data of Tables 1
and 2 and the information contained in the other transition
vectors, as these specify the admissible intervals of the various
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converged quickly and showed satisfactory mixing. In all analyses
we took a burn-in of 25,000 cycles and a simulation length of
200,000 cycles. Thinning was applied by taking only each 100th
cycle as a sample from the posterior distribution. We performed
four replicate simulations to check the precision of the parameter
estimates obtained by the above procedures. These simulations
yielded parameter estimates and 95% credible intervals that were
close to those given in Table 4.
To choose between models of different complexity we made use
of Bayes factors (BF) [37]. To this end the marginal likelihoods of
competing models were estimated by importance sampling using
the harmonic means of the posterior likelihood values [37]. The BF
converged slowly, possibly because of the high dimensionality of the
model (86 unobserved transition events plus 5–9 epidemiological
parameters),the mutualdependenciesofthe unobserved transitions,
and the factthat the likelihood is strongly affected by the parameters
definingthevariancesofthe latentand infectiousperiodsif thoseare
small. However, this did not appear to be a major practical problem
as differences between competing models were usually large. When
reported in the text we calculated the BF of the pair of simulations
that had the smallest difference in marginal likelihoods.
A suite of Bayesian analyses were performed for the experiments
w i t hu n v a c c i n a t e db i r d s .F i r s t ,w ea n a l y z e dt h el o w -a n dh i g h - d o s e
experiments of Tables 1 and 2 separately (scenarios A1 and A2).
Second, we pooled the data of the low- and high-dose experiments
(scenario B). We then considered an integrated analysis of the two
experiments that allowed for differences in the infectious periods in
the low- versus high-dose experiments (scenario C). Finally, we
considered a scenario which allowed for differences in the
epidemiological characteristics of the inoculated and contact birds
(scenario D).
Simulated epidemics
To explore the implications of the parameters estimated by the
above procedures for the pathogen dynamics in large groups of
birds, we performed simulations of the stochastic SEIR model
using the Sellke construction [16]. In the simulations we assumed
gamma distributed latent and infectious periods, and used the
medians of the parameter estimates of Table 4 as input values. The
programs for the MCMC analyses and simulated epidemics were
written in Mathematica 6.0 (www.wolfram.com).
Supporting Information
Figure S1 Bayesian analysis of the low-dose experiment
(Table 1). Shown are samples of the mean of the latent period
(A), variance of the latent period (B), mean of the infectious period
(C), variance of the infectious period (D), transmission rate
parameter (E), mean of the infectious period versus transmission
rate parameter (F), mean versus variance of the latent period (G),
and mean versus variance of the infectious period (H).
Found at: doi:10.1371/journal.ppat.1000281.s001 (4.87 MB TIF)
Figure S2 Bayesian analysis of the high-dose experiment
(Table 2). Shown are samples of the mean of the latent period
(A), variance of the latent period (B), mean of the infectious period
(C), variance of the infectious period (D), transmission rate
parameter (E), mean of the infectious period versus transmission
rate parameter (F), mean versus variance of the latent period (G),
and mean versus variance of the infectious period (H).
Found at: doi:10.1371/journal.ppat.1000281.s002 (4.80 MB TIF)
Figure S3 Bayesian analysis of the combined experiments
(scenario B). Shown are samples of the mean of the latent
period (A), variance of the latent period (B), mean of the
infectious period (C), variance of the infectious period (D),
transmission rate parameter (E), mean of the infectious period
versus transmission rate parameter (F), mean versus variance of
the latent period (G), and mean versus variance of the infectious
period (H).
Found at: doi:10.1371/journal.ppat.1000281.s003 (4.83 MB TIF)
Figure S4 Bayesian analysis of the combined experiments
(scenario C). Shown are samples of the mean of the latent period
(A), variance of the latent period (B), mean of the infectious period
(C), variance of the infectious period (D), transmission rate
parameter (E), mean of the infectious period versus transmission
rate parameter (F), mean versus variance of the latent period (G),
and mean versus variance of the infectious period (H). Red and
blue dots refer to parameters characterizing the low- and high-
dose experiments, respectively.
Found at: doi:10.1371/journal.ppat.1000281.s004 (5.48 MB TIF)
Figure S5 Bayesian analysis of the combined experiments
(scenario D). Shown are samples of the mean of the latent period
(A), variance of the latent period (B), mean of the infectious period
(C), variance of the infectious period (D), transmission rate
parameter (E), mean of the infectious period versus transmission
rate parameter (F), mean versus variance of the latent period (G),
and mean versus variance of the infectious period (H). Blue and
red dots refer to parameters characterizing the inoculated and
contact birds, respectively.
Found at: doi:10.1371/journal.ppat.1000281.s005 (6.38 MB TIF)
Table S1 Overview of the experiments with vaccinated birds.
Found at: doi:10.1371/journal.ppat.1000281.s006 (0.03 MB
DOC)
Table S2 Overview of experiment #1 (see Table S1) with
vaccinated birds inoculated with a low virus dose. The vaccine
contained a heterologous H5N2 vaccine strain (A/Turkey/
England/N28/73).
Found at: doi:10.1371/journal.ppat.1000281.s007 (0.06 MB
DOC)
Table S3 Overview of experiment #2 (see Table S1) with
vaccinated birds inoculated with a low virus dose. The vaccine
contained a heterologous H5N2 vaccine strain (A/Turkey/
England/N28/73), from a different producer than in Table S2.
Found at: doi:10.1371/journal.ppat.1000281.s008 (0.05 MB
DOC)
Table S4 Overview of experiment #3 (see Table S1) with
vaccinated birds inoculated with a low virus dose. The vaccine
contained a heterologous H5N2 vaccine strain (A/Chicken/
Mexico/232/94/CPA).
Found at: doi:10.1371/journal.ppat.1000281.s009 (0.06 MB
DOC)
Table S5 Overview of experiment #4 (see Table S1) with
vaccinated birds inoculated with a high virus dose. The vaccine
contained a homologous H5N1 vaccine strain (A/Chicken/Legok/
2003).
Found at: doi:10.1371/journal.ppat.1000281.s010 (0.06 MB
DOC)
Table S6 Overview of experiment #5 (see Table S1) with
vaccinated birds inoculated with a high virus dose. The vaccine
contained a homologous H5N1 vaccine strain (A/Chicken/
Legok/2003), from a different producer than in Table S5.
Found at: doi:10.1371/journal.ppat.1000281.s011 (0.06 MB
DOC)
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PLoS Pathogens | www.plospathogens.org 12 January 2009 | Volume 5 | Issue 1 | e1000281Table S7 Overview of experiment #6 (see Table S1) with
vaccinated birds inoculated with a high virus dose. The vaccine
contained a heterologous H5N2 vaccine strain (A/Chicken/
Mexico/232/94/CPA).
Found at: doi:10.1371/journal.ppat.1000281.s012 (0.06 MB
DOC)
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